Menu

• Ask a Health Expert about CYSTITIS HAEMORRHAGIC
• Post Your Side Effect related to CYSTITIS HAEMORRHAGIC
• CYSTITIS HAEMORRHAGIC and FDA Warnings
• CYSTITIS HAEMORRHAGIC in Patients Wiki
• Report CYSTITIS HAEMORRHAGIC in Drug Side Effect Survey

CYSTITIS HAEMORRHAGIC side effect

What is CYSTITIS HAEMORRHAGIC ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Melphalan Side Effects Report #5661266-3
Consumer or non-health professional from JAPAN reported MELPHALAN problem on Feb 28, 2008. Female patient, child 11 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with CYTARABINE, THIOTEPA, CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT, TACROLIMUS, METHOTREXATE, METHYLPREDNISOLONE. Patient recovered.

Melphalan Side Effects Report #5677167-0
MELPHALAN problem was reported by a Physician from JAPAN on Mar 17, 2008. Female patient, child 11 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with CYTARABINE, THIOTEPA, CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT, TACROLIMUS, METHOTREXATE, METHYLPREDNISOLONE. Patient recovered.

Gleevec Side Effects Report #5626001-3
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Feb 07, 2008. Male patient, 19 years of age, weighting 125.7 lb, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hypoglycaemia, malignant neoplasm progression, . GLEEVEC dosage: unknown. During the same period patient was treated with GEFITINIB. Patient died on 09/01/2006.

Fludarabine Side Effects Report #5635614-4
FLUDARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Male patient, child 8 years of age, was diagnosed with immunosuppression, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pneumonia, reversible posterior leukoencephalopathy syndrome, . FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE. Patient recovered.


Enalapril Side Effects Report #5584649-9
Pharmacist from JAPAN reported ENALAPRIL MALEATE problem on Dec 18, 2007. Female patient was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ENALAPRIL MALEATE dosage: unknown. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5535118-3
PROGRAF problem was reported by a Physician from JAPAN on Nov 15, 2007. Male patient, child 4 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pseudomembranous colitis, thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.

Mylotarg Side Effects Report #5535978-6
Physician from JAPAN reported MYLOTARG problem on Nov 30, 2007. Male patient, 52 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . MYLOTARG dosage: unknown. During the same period patient was treated with ZOVIRAX. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5563347-1
VIDAZA problem was reported by a Physician from UNITED STATES on Oct 23, 2007. Female patient, 78 years of age, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, platelet count decreased, urinary tract infection, . VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD. Patient was hospitalized. Patient recovered.

Cellcept Side Effects Report #5565556-4
Physician from JAPAN reported CELLCEPT problem on Sept 28, 2005. Male patient, 61 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, cytomegalovirus infection, thrombotic microangiopathy, . CELLCEPT dosage: unknown. During the same period patient was treated with CYCLOSPORINE, METHOTREXATE, PREDNISOLONE, FLUDARA, BUSULPHAN, ANTITHYMOCYTE GLOBULIN. Patient died.


Iressa Side Effects Report #5571074-X
IRESSA problem was reported by a Physician from CHINA on Dec 14, 2007. Male patient, 45 years of age, was diagnosed with bronchioloalveolar carcinoma and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, dry skin, pruritus, rash papular, . IRESSA dosage: unknown. Patient recovered.

Cyclophosphamide Side Effects Report #5523491-1
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Nov 19, 2007. Male patient, 14 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . CYCLOPHOSPHAMIDE dosage: 3 DAILY DOSES WITH 50MG/KG/DOSE. During the same period patient was treated with ETOPOSIDE, MESNA. Patient recovered.

Zaditen Side Effects Report #5474026-3
ZADITEN problem was reported by a Pharmacist from JAPAN on Sept 21, 2007. Female patient was diagnosed with asthma and was treated with ZADITEN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ZADITEN dosage: 2 MG/DAY. Patient was hospitalized. Patient recovered.

Busulfan Side Effects Report #5447579-9
Health Professional from JAPAN reported BUSULFAN problem on Aug 22, 2007. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, disseminated intravascular coagulation, malaise, multi-organ failure, nausea, neutropenia, staphylococcal sepsis, stem cell transplant, . BUSULFAN dosage: 6.2 ML;BID;IV; 6.2 ML;QID;IV; 6.2 ML;X1;IV. During the same period patient was treated with PHENYTOIN, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient died on 05/05/2007.

Zaditen Side Effects Report #5465275-9
ZADITEN problem was reported by a Pharmacist from JAPAN on Sept 14, 2007. Female patient was diagnosed with asthma and was treated with ZADITEN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . ZADITEN dosage: 2 MG/DAY. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5413136-3
Physician from UNITED STATES reported VIDAZA problem on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection, . VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5416842-X
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Male patient, weighting 183.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, dehydration, dysuria, obstructive uropathy, proctalgia, renal failure acute, . FLUOROURACIL dosage: 7120 MG. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5386686-6
Consumer or non-health professional from GERMANY reported CYCLOPHOSPHAMIDE problem on July 04, 2007. Male patient, 52 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, multi-organ failure, urosepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with UROMITEXAN, HYDROCORTISONE, FOSCARNET. Patient died on 01/27/2007.

Mycophenolate Side Effects Report #5403916-2
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Sept 22, 2003. Female patient, 41 years of age, was diagnosed with necrotising scleritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, hepatic enzyme abnormal, hypertension, paraesthesia, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, METHOTREXATE, CYCLOPHOSPHAMIDE. Patient recovered.

Cyclophosphamide Side Effects Report #5386686-6
Consumer or non-health professional from GERMANY reported CYCLOPHOSPHAMIDE problem on July 04, 2007. Male patient, 52 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, multi-organ failure, urosepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with UROMITEXAN, HYDROCORTISONE, FOSCARNET. Patient died on 01/27/2007.


Mycophenolate Side Effects Report #5403916-2
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Sept 22, 2003. Female patient, 41 years of age, was diagnosed with necrotising scleritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, hepatic enzyme abnormal, hypertension, paraesthesia, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, METHOTREXATE, CYCLOPHOSPHAMIDE. Patient recovered.

Cyclophosphamide Side Effects Report #5759914-2
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 28, 2008. Male patient, 56 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with MESNA. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5763580-X
GLEEVEC problem was reported by a Health Professional from JAPAN on May 29, 2008. Male patient, 19 years of age, weighting 125.7 lb, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hypoglycaemia, malignant neoplasm progression, . GLEEVEC dosage: unknown. During the same period patient was treated with GEFITINIB. Patient was hospitalized. Patient died on 09/01/2006.

Elspar Side Effects Report #5764173-0
Consumer or non-health professional from UNITED STATES reported ELSPAR problem on May 23, 2008. Male patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, leukaemia recurrent, mucosal inflammation, pulmonary veno-occlusive disease, venoocclusive liver disease, . ELSPAR dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, METHOTREXATE, TENEPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Iressa Side Effects Report #5707467-7
IRESSA problem was reported by a Physician from JAPAN on Apr 08, 2008. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . IRESSA dosage: unknown. Patient recovered.

Fludarabine Side Effects Report #5720946-1
Health Professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Apr 25, 2008. Male patient was diagnosed with chronic myeloid leukaemia and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, cytomegalovirus viraemia, encephalopathy, headache, hydronephrosis, infection, mental status changes, renal failure acute, . FLUDARABINE PHOSPHATE dosage: 51 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA, RABBIT ATG. Patient was hospitalized. Patient recovered.

Cymbalta Side Effects Report #5361826-3
CYMBALTA problem was reported by a Physician from SLOVAKIA (Slovak Republic) on June 07, 2007. Female patient, 79 years of age, was diagnosed with depression, abnormal behaviour, agitation, cognitive disorder, hypertension, osteoporosis, arrhythmia, myocardial ischaemia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hepatic enzyme increased, renal failure, . CYMBALTA dosage: 60 MG, QOD. During the same period patient was treated with RISPERDAL, PROTHAZIN, PIRABENE, LORISTA, CALCITONIN, DIGOXIN, BISOPROLOL FUMARATE, MODURETIC. Patient was hospitalized. Patient died on 05/17/2007.

Temodar Side Effects Report #5364379-9
Pharmacist from UNITED STATES reported TEMODAR problem on June 10, 2007. Male patient was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . TEMODAR dosage: unknown. Patient recovered.

Cymbalta Side Effects Report #5367859-5
CYMBALTA problem was reported by a Physician from SLOVAKIA (Slovak Republic) on June 13, 2007. Female patient, 79 years of age, was diagnosed with depression, abnormal behaviour, agitation, cognitive disorder, hypertension, osteoporosis, arrhythmia, myocardial ischaemia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hepatic enzyme increased, renal failure, . CYMBALTA dosage: 60 MG, QOD. During the same period patient was treated with RISPERDAL, PROTHAZIN, PIRABENE, LORISTA, CALCITONIN, DIGOXIN, BISOPROLOL FUMARATE, MODURETIC. Patient was hospitalized. Patient died on 05/17/2007.

Cymbalta Side Effects Report #5368815-3
Physician from SLOVAKIA (Slovak Republic) reported CYMBALTA problem on June 13, 2007. Female patient, 79 years of age, was diagnosed with depression, abnormal behaviour, agitation, cognitive disorder, hypertension, osteoporosis, arrhythmia, myocardial ischaemia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, hepatic enzyme increased, renal failure, . CYMBALTA dosage: 60 MG, QOD. During the same period patient was treated with RISPERDAL, PROTHAZIN, PIRABENE, LORISTA, CALCITONIN, DIGOXIN, BISOPROLOL FUMARATE, MODURETIC. Patient was hospitalized. Patient died on 05/17/2007.

Prograf Side Effects Report #5370616-7
PROGRAF problem was reported by a Physician from JAPAN on June 13, 2007. Male patient was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, postrenal failure, shock, upper gastrointestinal haemorrhage, . PROGRAF dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, MELPHALAN. Patient died on 03/13/2004.

Bevacizumab Side Effects Report #5292260-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Apr 04, 2007. Female patient, weighting 132.3 lb, was diagnosed with urinary tract infection, insomnia, bronchitis chronic, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, KEFLEX, AMBIEN, DECADRON, SPIRIVA, AVALIDE. Patient was hospitalized. Patient recovered.

Iressa Side Effects Report #5293264-6
IRESSA problem was reported by a Physician from JAPAN on Apr 05, 2007. Female patient, weighting 112.4 lb, was diagnosed with lung adenocarcinoma recurrent and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, platelet count decreased, . IRESSA dosage: unknown. During the same period patient was treated with CONIEL, LIPITOR, BISOLVON, SEFTAC, MYSLEE, NEOPAREN. Patient died on 12/17/2006.

Busulfan Side Effects Report #5299878-1
Health Professional from JAPAN reported BUSULFAN problem on Mar 27, 2007. Male patient, 54 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, graft versus host disease, hepatic function abnormal, pyrexia, thrombotic microangiopathy, venoocclusive liver disease, . BUSULFAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, VALPROATE. Patient died on 12/19/2006.

Busulfan Side Effects Report #5269623-4
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2007. Male patient, 54 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, graft versus host disease, thrombotic microangiopathy, venoocclusive liver disease, weight increased, . BUSULFAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, VALPROATE. Patient died on 12/19/2006.

Iressa Side Effects Report #5270029-2
Physician from UNITED STATES reported IRESSA problem on July 30, 2003. Male patient, weighting 185.2 lb, was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . IRESSA dosage: unknown. During the same period patient was treated with OXYCONTIN, TOPROL, ZOCOR. Patient recovered.

Iressa Side Effects Report #5270033-4
IRESSA problem was reported by a Physician from UNITED STATES on July 30, 2003. Female patient, 62 years of age, weighting 143.3 lb, was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, . IRESSA dosage: unknown. During the same period patient was treated with PROTONIX, NORVASC, BETAPACE, COUMADIN, MORPHINE, GAVITENSIN, LIDOCAINE, VISCON. Patient recovered.

Mylotarg Side Effects Report #5276551-7
Physician from JAPAN reported MYLOTARG problem on Mar 15, 2007. Female patient, weighting 127.9 lb, was diagnosed with acute myeloid leukaemia, osteoporosis, prophylaxis, hypertension, gastritis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, gastrointestinal haemorrhage, haematuria, renal failure acute, . MYLOTARG dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, MUCOSTA, BAKTAR, MAGNESIUM OXIDE, TOWAMIN, SELBEX. Patient was hospitalized. Patient died on 07/20/2006.

Prograf Side Effects Report #5285326-4
PROGRAF problem was reported by a Physician from JAPAN on Mar 16, 2007. Male patient, child 10 years of age, weighting 61.29 lb, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, cytomegalovirus infection, hypertension, reversible posterior leukoencephalopathy syndrome, therapeutic agent toxicity, . PROGRAF dosage: 0.03 MG/KG D. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN, METHOTREXATE. Patient recovered.

Azathioprine Side Effects Report #5671843-1
Consumer or non-health professional from UNITED KINGDOM reported AZATHIOPRINE problem on Feb 26, 2008. Female patient, 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cystitis haemorrhagic, jc virus infection, progressive multifocal leukoencephalopathy, respiratory failure, weight decreased, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, PREDNISOLONE. Patient died.

Prednisolone Side Effects Report #5685309-6
PREDNISOLONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 20, 2008. Female patient, 45 years of age, was diagnosed with systemic lupus erythematosus and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cystitis haemorrhagic, dysphagia, herpes zoster, pneumonia, progressive multifocal leukoencephalopathy, respiratory failure, weight decreased, . PREDNISOLONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, AZATHIOPRINE, RITUXIMAB, CORTICOSTEROIDS. Patient died.

Thalomid Side Effects Report #5637800-6
Physician from UNITED STATES reported THALOMID problem on Feb 12, 2008. Female patient was diagnosed with carcinoid tumour of the pancreas, metastatic neoplasm and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: constipation, cystitis haemorrhagic, deep vein thrombosis, dizziness, dry mouth, fatigue, orthostatic hypotension, peripheral sensory neuropathy, somnolence, . THALOMID dosage: 200 MG, DAILY, ORAL; 400 MG, DAILY, ORAL. Patient recovered.

Busulfan Side Effects Report #5585749-X
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: brain stem haemorrhage, cystitis haemorrhagic, disseminated intravascular coagulation, gastrointestinal haemorrhage, infection, pulmonary haemorrhage, sepsis, . BUSULFAN dosage: 29.32 ML; QD; IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE. Patient died on 12/17/2006.

Dacarbazine Side Effects Report #5613644-6
Consumer or non-health professional from UNITED STATES reported DACARBAZINE problem on Jan 16, 2008. Male patient, 63 years of age, was diagnosed with metastatic malignant melanoma and was treated with DACARBAZINE. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, cystitis haemorrhagic, metastases to central nervous system, . DACARBAZINE dosage: 600MG/M2; 700MG/M2; 850 MG/. Patient was hospitalized. Patient died.

Alkeran Side Effects Report #5505311-4
ALKERAN problem was reported by a Physician from JAPAN on Oct 29, 2007. Male patient, 77 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma, osteoporosis, gastritis, supraventricular tachycardia, angina pectoris, hyperlipidaemia, benign prostatic hyperplasia, lumbar vertebral fracture and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: anaemia, cystitis haemorrhagic, . ALKERAN dosage: 4MG PER DAY. During the same period patient was treated with PREDONINE, PRIMOBOLAN, ZANTAC, DIGOXIN, AMLODIPINE, PRAVASTATIN, HARNAL, MOBIC. Patient was hospitalized. Patient died on 11/09/2006.

Holoxan Side Effects Report #5489841-X
Consumer or non-health professional from UNITED STATES reported HOLOXAN problem on Oct 09, 2007. Male patient, child 3 years of age, weighting 33.07 lb, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, encephalopathy, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, KETAMINE, UROMITEXAN, ACTINOMYCIN, ZOFRAN, VOGALENE. Patient was hospitalized. Patient recovered.

Holoxan Side Effects Report #5490537-9
HOLOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Male patient, child 3 years of age, weighting 33.07 lb, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, encephalopathy, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, KETAMINE, UROMITEXAN, ACTINOMYCIN, ZOFRAN, VOGALENE. Patient was hospitalized. Patient recovered.

Cymbalta Side Effects Report #5500863-2
Physician from SLOVAKIA (Slovak Republic) reported CYMBALTA problem on Oct 22, 2007. Female patient, 79 years of age, was diagnosed with depression, abnormal behaviour, agitation, cognitive disorder, hypertension, osteoporosis, myocardial ischaemia, arrhythmia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, cystitis haemorrhagic, hepatic enzyme increased, . CYMBALTA dosage: 60 MG, QOD. During the same period patient was treated with RISPERDAL, PROTHAZIN, PIRABENE, LORISTA, MODURETIC, CALCITONIN, BISOPROLOL FUMARATE, DIGOXIN. Patient was hospitalized. Patient died on 05/17/2007.

Reyataz Side Effects Report #5412580-8
REYATAZ problem was reported by a Health Professional from FRANCE on Aug 08, 2007. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with REYATAZ. After drug was administered, patient experienced the following problems/side effects: calculus urinary, cystitis haemorrhagic, . REYATAZ dosage: unknown. During the same period patient was treated with TELZIR, EFFEXOR, LARGACTIL, NEURONTIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Telzir Side Effects Report #5413712-8
Consumer or non-health professional from FRANCE reported TELZIR problem on Aug 08, 2007. Female patient, 45 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: calculus urinary, cystitis haemorrhagic, . TELZIR dosage: unknown. During the same period patient was treated with REYATAZ, EFFEXOR, LARGACTIL, NEURONTIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Holoxan Side Effects Report #5429570-1
HOLOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, UROMITEXAN, ACTINOMYCIN. Patient was hospitalized. Patient recovered.

Holoxan Side Effects Report #5431629-X
Consumer or non-health professional from UNITED STATES reported HOLOXAN problem on Aug 20, 2007. Male patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, cystitis haemorrhagic, hyperhidrosis, hypotension, hypotonia, malaise, . HOLOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, UROMITEXAN, ACTINOMYCIN. Patient was hospitalized. Patient recovered.